Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer-Reference-Cited by-同舟云学术

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

Published:2015-10-23 Issue:11 Volume:15 Page:668-679
ISSN:1474-175X
Container-title:Nature Reviews Cancer
language:en
Short-container-title:Nat Rev Cancer

Author:

Bowtell David D.,Böhm Steffen,Ahmed Ahmed A.,Aspuria Paul-Joseph,Bast Robert C.,Beral Valerie,Berek Jonathan S.,Birrer Michael J.,Blagden Sarah,Bookman Michael A.,Brenton James D.,Chiappinelli Katherine B.,Martins Filipe Correia,Coukos George,Drapkin Ronny,Edmondson Richard,Fotopoulou Christina,Gabra Hani,Galon Jérôme,Gourley Charlie,Heong Valerie,Huntsman David G.,Iwanicki Marcin,Karlan Beth Y.,Kaye Allyson,Lengyel Ernst,Levine Douglas A.,Lu Karen H.,McNeish Iain A.,Menon Usha,Narod Steven A.,Nelson Brad H.,Nephew Kenneth P.,Pharoah Paul,Powell Daniel J.,Ramos Pilar,Romero Iris L.,Scott Clare L.,Sood Anil K.,Stronach Euan A.,Balkwill Frances R.

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://www.nature.com/articles/nrc4019.pdf

Reference184 articles.

1. Vaughan, S. et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat. Rev. Cancer 11, 719–725 (2011).

2. The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70 (2012).

3. Mehra, K. et al. STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis. Front. Biosci. (Elite Ed) 3, 625–634 (2011).

4. Lee, Y. et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 211, 26–35 (2007).

5. Piek, J. M. et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J. Pathol. 195, 451–456 (2001).

Cited by 879 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BBOX1 mediates metabolic reprogramming driven by hypoxia and participates in the malignant progress of high-grade serous ovarian cancer;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-12

2. Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations;Gynecologic Oncology;2024-11

3. Reprogramming of normal fibroblasts into ovarian cancer-associated fibroblasts via non-vesicular paracrine signaling induces an activated fibroblast phenotype;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

4. HPV-YAP1 oncogenic alliance drives malignant transformation of fallopian tube epithelial cells;EMBO Reports;2024-09-13

5. Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways;Molecular Oncology;2024-09-08